A computational approach involving molecular docking refined with molecular dynamics simulations as well as a pharmacophore analysis could pave the way for new insights on potential DPP-4 inhibitors for type-2 diabetes treatments, as successfully described in the literature about other case studies [17,18,19,20]. Here, DPP4 is linked to type 2 diabetes mellitus.